Rapid Test Market Growth, Revenue Share Analysis, Company Profiles, and Forecast To 2030

Comments · 119 Views

The global Rapid Test market was valued at USD 24.55 billion in 2018 and is expected to reach USD 24.26 Billion by year 2028, at a CAGR of 7.30%.

The global Rapid Test Market report published by Reports and Data assesses the Rapid Test Market with regards to market size, market share, revenue growth, key segments, and regional bifurcation. The global Rapid Test Market is highly fragmented with numerous players operating on a global and regional level. The companies are engaged in mergers and acquisitions, joint ventures, and collaborations along with product advancements and RD activities to cater to the growing global demand and gain a robust footing in the market. Key companies operating in the market and profiled in the report include: Akers Biosciences, Inc., Alere Inc. (Abbott Laboratories), Becton, Dickinson and Company, Bio-rad Laboratories, Inc., Cepheid, Inc., Hologic, Inc., Meridian Bioscience, Inc., OraSure Technologies, Inc., Quidel Corporation, and Roche Diagnostics.

According to RnD, The global Rapid Test market was valued at USD 24.55 billion in 2018 and is expected to reach USD 24.26 Billion by year 2028, at a CAGR of 7.30%. during the forecast period of 2021-2028.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2283

The pharma and healthcare industry is expected to observe significant growth over the coming years attributed to the increasing incidence of chronic diseases across the globe, growing geriatric patient pool, availability of advanced and minimally invasive surgical and diagnostics procedures, favorable reimbursement scenario, and presence of a robust product pipeline of drugs and therapeutics. In addition, growing integration of IoT, ML, and AI in medical procedures and equipment along with rapid progress in drug design and development. Combination of innovation and technology has brought about massive changes in the healthcare industry and the rapid adoption of telemedicine, remote consultation, and e-prescription have significantly contributed to the revenue growth of the market.

Request a customization on the report @ https://www.reportsanddata.com/request-customization-form/2283

Asia Pacific is expected to lead the market growth over the coming years owing to rapid advancements in healthcare sector in APAC countries such as India, China, and Japan. North America is anticipated to register highest market growth over the forecast period attributed to increasing availability of robust healthcare and clinical settings, legalization of medical marijuana, favorable reimbursement scenario, presence of key market players, and rapid technological advancements in the region.

For the purpose of this study, Reports and Data have segmented the Rapid Test market on the basis of product type, application, end use, and region:

Product Type (Revenue, USD Million; 2018–2028)

  • Over-the-Counter (OTC) Rapid Test Product
  • Professional Rapid Test Product

Application (Revenue, USD Million; 2018–2028)

  • Infectious Disease
  • Cardiology
  • Oncology
  • Pregnancy Fertility
  • Toxicology
  • Glucose Monitoring
  • Others

End Use (Revenue, USD Million; 2018–2028)

  • Hospital Clinic
  • Diagnostic Laboratory
  • Home Care
  • Others

Regional Outlook (Revenue in USD Million; 2018–2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East Africa
  • Latin America
    • Brazil

Growing popularity of over-the-counter medications driving market growth

Growing incidence of acute and chronic diseases and lesser access to advanced medical facilities owing to low disposable income levels are driving the demand for over-the-counter medications. Availability of generic and low-cost alternatives to medical therapies are some other factors playing a major role in driving demand for over-the-counter medications.

Restriction on product launches and RD activities to hamper market growth

Imposition of strict government regulations and shortage of funds have put a halt on the product launches and RD activities and are expected to restrain market growth over the forecast period. In addition, launch of expensive drugs and therapies and increasing regulations regarding safety and approvals are also hampering market growth.

Thank you for reading our report. For more details please connect with us and our team will ensure the report is customized to meet all the needs of clients. The report also offers a comprehensive regional analysis and specific countries can be included in the report according to the requirements.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W, Head of Business Development

Reports And Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

LinkedIn | Twitter | Blogs

 

 

Comments